Today: 16 May 2026

US Stock Market (After Hours): Dow, S&P 500, Nasdaq Slide as Iran Risk Overtakes Earnings

US Stock Market (After Hours): Dow, S&P 500, Nasdaq Slide as Iran Risk Overtakes Earnings

U.S. stocks fell Tuesday, with the S&P 500, Nasdaq, and Dow all down about 0.6% as early gains reversed. Brent crude jumped 3.1% to $98.48 on uncertainty over U.S.-Iran talks. UnitedHealth rose 7% after strong earnings, while Apple slipped on CEO transition news. The 10-year Treasury yield climbed as investors weighed retail sales and Fed leadership signals.
XRP Price Today: Why the $1.42 Level Matters as Bitcoin Fund Flows Return

XRP Price Today: Why the $1.42 Level Matters as Bitcoin Fund Flows Return

XRP traded near $1.42 Tuesday, down about 1% over 24 hours, with 24-hour turnover at $2.37 billion and a market value near $87 billion. CoinShares reported $56 million in outflows from XRP investment products last week, while Bitcoin and Ether drew strong inflows. Coinbase Derivatives filed to offer TAS block trades for XRP starting May 1. Ripple outlined a post-quantum cryptography roadmap for the XRP Ledger, targeting completion by 2028.
Bitcoin Price Today: BTC Slips Below $75,000 as Fed Doubts Stall a Fresh Rally

Bitcoin Price Today: BTC Slips Below $75,000 as Fed Doubts Stall a Fresh Rally

Bitcoin fell 1.7% to about $74,985 on Tuesday after briefly nearing $77,000, as traders responded to signals the Federal Reserve may not cut rates soon. Spot bitcoin ETFs saw strong inflows, with BlackRock’s IBIT fund attracting $906 million last week. Iran’s uncertainty over Gulf peace talks and oil price concerns weighed on risk assets. Ether dropped 1.4% to $2,296.
Hims & Hers Stock Slides as Amazon Enters the GLP-1 Weight-Loss Race

Hims & Hers Stock Slides as Amazon Enters the GLP-1 Weight-Loss Race

Hims & Hers Health shares fell 1.6% to $30.52 Tuesday after Amazon launched a GLP-1 weight-management program through One Medical, intensifying competition in telehealth weight loss. Amazon said its program will offer same-day pharmacy delivery in nearly 3,000 cities and 24/7 prescription renewals. Eli Lilly and Novo Nordisk shares also declined. Hims is shifting away from compounded GLP-1s toward branded, FDA-approved drugs.
Nokia Q1 Earnings Preview: AI Push Meets North America Test

Nokia Q1 Earnings Preview: AI Push Meets North America Test

Nokia will report first-quarter results Thursday, with analysts expecting €253 million in adjusted operating profit on €4.56 billion in sales. The company will debut a new reporting structure with expanded segment detail. Consensus sees adjusted EPS at €0.04, up from €0.03 a year ago. Recent deals with TIM Brasil, Deutsche Telekom, and Orange highlight Nokia’s push into AI-driven network infrastructure.
Plug Power Stock Slips as Court Lets Part of Investor Suit Move Ahead During Louisiana Plant Tour

Plug Power Stock Slips as Court Lets Part of Investor Suit Move Ahead During Louisiana Plant Tour

A Delaware judge allowed investors to pursue part of a securities lawsuit against Plug Power over statements on hydrogen production targets and revenue forecasts. The ruling came as Plug hosted an investor tour of its Louisiana hydrogen plant with Oppenheimer. Plug shares fell about 5% to $3.06 in early afternoon trading. The company reaffirmed its goal of positive EBITDAS in the fourth quarter of 2026.
Intel Earnings Preview: AI Server-Chip Shortages Put Turnaround to the Test

Intel Earnings Preview: AI Server-Chip Shortages Put Turnaround to the Test

Intel will report first-quarter results Thursday after earlier warning of struggles to meet AI server chip demand. Analysts expect revenue to fall 1.9% to $12.42 billion and adjusted earnings to drop nearly 90%, despite projected growth in its data center and AI segment. Intel recently bought out Apollo’s stake in its Irish fab for $14.2 billion. Lead times for some server CPUs could reach six months.
US Stock Market Today: S&P 500, Dow, Nasdaq Slip as Oil Jumps and Fed Uncertainty Caps Rally

US Stock Market Today: S&P 500, Dow, Nasdaq Slip as Oil Jumps and Fed Uncertainty Caps Rally

The S&P 500 fell 0.32% to 7,086.48 Tuesday afternoon as rising oil prices and Treasury yields erased early gains. Brent crude climbed again after a 5.6% jump Monday, following U.S.-Iran ceasefire tensions. UnitedHealth raised its full-year outlook, and Amazon pledged up to $25 billion in Anthropic. March retail sales rose 1.7%, the biggest increase in a year.
NVIDIA Corporation Shares Slip as Google’s AI Chip Push Tests Inference Lead

NVIDIA Corporation Shares Slip as Google’s AI Chip Push Tests Inference Lead

Nvidia shares dropped $1.98 to $200.08 Tuesday after reports that Google is in talks with Marvell Technology on new AI chips. The move comes ahead of Google Cloud Next and highlights ongoing efforts by major cloud providers to reduce reliance on Nvidia processors. Nvidia’s market value stood at about $4.53 trillion after the decline. Google and Marvell did not comment on the reported discussions.
AT&T and Citi Refresh Points Plus Card With New Rewards, Bill Discounts and No Foreign Fees

AT&T and Citi Refresh Points Plus Card With New Rewards, Bill Discounts and No Foreign Fees

AT&T and Citigroup updated the AT&T Points Plus World Mastercard, adding 2x ThankYou Points on AT&T purchases and waiving foreign transaction fees. The card still offers up to $240 in annual statement credits after qualifying spend, with discounts for eligible wireless and internet customers. The new perks are available to current and new cardholders. AT&T shares traded at $26.14 midday Tuesday.
21 April 2026
Citi Wealth Turns to Advyzon for Global Unified Managed Account Rollout as Banks Push Deeper Into Alternatives

Citi Wealth Turns to Advyzon for Global Unified Managed Account Rollout as Banks Push Deeper Into Alternatives

Citi Wealth will partner with Advyzon to launch a global unified managed account program, starting in late 2026 for select private banking clients. The platform will combine ETFs, mutual funds, separately managed accounts, and alternatives in a single structure, integrating BlackRock’s portfolio solutions. Citi’s wealth unit reported $3.1 billion in Q1 revenue, up 11% from last year, but net new investment assets fell 11%.
This Little-Known AI Power Stock Is Surging. Its Next Test Comes May 5

This Little-Known AI Power Stock Is Surging. Its Next Test Comes May 5

Navitas shares surged nearly 20% Tuesday morning, trading around $15.82 with volume over 53 million, as investors focused on its AI data-center power role. The company, which designs GaN and SiC power semiconductors, will report first-quarter results May 5. Full-year 2025 revenue dropped to $45.92 million from $83.3 million in 2024 after shifting away from mobile chargers.
21 April 2026
Vanguard Just Split Five ETFs — What Changed for VGT, VUG, MGK, VOOG and VO Today

Vanguard Just Split Five ETFs — What Changed for VGT, VUG, MGK, VOOG and VO Today

Vanguard’s five equity index ETFs began trading at split-adjusted prices Tuesday, lowering share prices without changing investors’ stakes. VGT opened at $101.45, VUG at $81.95, MGK at $82.78, VOOG at $76.61, and VO at $76.92. The splits, ranging from 4-for-1 to 8-for-1, applied to holders as of April 20 and have no tax impact, according to Vanguard.
Stock Market Today: Dow, S&P 500 And Nasdaq Turn Lower As Apple CEO Change, Warsh Hearing And Iran Talks Hit Wall Street

Stock Market Today: Dow, S&P 500 And Nasdaq Turn Lower As Apple CEO Change, Warsh Hearing And Iran Talks Hit Wall Street

Apple shares fell after the company named John Ternus to succeed Tim Cook as CEO, while U.S. stocks turned negative amid uncertainty over the Federal Reserve leadership and U.S.-Iran ceasefire talks. UnitedHealth’s strong results helped limit losses. Brent crude traded in the mid-$90s ahead of Wednesday’s scheduled expiration of the U.S.-Iran ceasefire agreement.
Eli Lilly to Buy Kelonia for Up to $7 Billion as In Vivo CAR-T Gains Ground

Eli Lilly to Buy Kelonia for Up to $7 Billion as In Vivo CAR-T Gains Ground

Eli Lilly will acquire Boston-based Kelonia Therapeutics for up to $7 billion in cash, including $3.25 billion upfront, to expand into in vivo CAR-T cancer therapies. Kelonia’s KLN-1010, in Phase 1 for multiple myeloma, generates engineered T-cells inside the patient. The deal marks Lilly’s third Massachusetts biotech purchase in 2026. Kelonia had 62 employees and nearly ran out of cash before the offer.
POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

POET Technologies shares surged 20% Tuesday, following an 18% gain Monday, after the company addressed U.S. shareholder tax concerns and announced plans to redomicile. Nearly 32.9 million shares traded by 10:21 a.m. ET, with the stock reaching $11.07 before settling at $10.34. Wolfpack Research disclosed a short position last week, sparking volatility. CFO Thomas Mika said POET expects not to qualify as a PFIC in 2026.
21 April 2026
Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

Rocket Lab shares rose 2% to $91.12 Tuesday after analysts raised price targets and the Pentagon detailed new space defense spending in its 2027 budget request. The company closed its $155 million Mynaric acquisition last week and reported a $190 million Pentagon launch contract in March, bringing its backlog above $2 billion. Rocket Lab now expects to launch its Neutron rocket in late 2026 after a test setback.
1 82 83 84 85 86 1,942

Stock Market Today

  • TJX Companies Stock Pullback: Valuation Concerns Amid Market Decline
    May 15, 2026, 9:03 PM EDT. TJX Companies (TJX) shares fell 4.6% last week and 8.1% over the past month despite a 12.1% one-year and 135.2% five-year return. The retailer faces scrutiny as its valuation scores 0/6 on standard metrics, signaling no undervaluation. A Discounted Cash Flow (DCF) model estimates TJX's intrinsic value at $105.36 per share, contrasting with its $147 market price, suggesting a 39.9% premium and potential overvaluation. Investors are monitoring factors such as store traffic and consumer trends, impacting market sentiment. This combination of recent price weakness and valuation analysis raises questions regarding the stock's growth prospects and fair market value.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop